OpenVSafe by OpenVAERS
Search V-safe

5HK-25028-70241

2 vaccinations 3 coded responses 11 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
212 / MD
Registered
2021-01-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-21
    Registered in v-safe
  4. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Swollen lymph node under armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Lymph node swelling under armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches
    Adult check-in
  7. 2021-02-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-02-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-02-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-02-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-19
    Survey response — 12 months, dose 2
    MedDRA: Laryngeal stenosis, Surgery, Tracheostomy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Diagnosed with idiopathic subglottic stenosis. Required surgery to open trachea. · Healthcare visit (other): Outpatient surgery
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-19
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2022-01-20

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-19Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-01-19 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-22

Systemic reaction (other): Swollen lymph node under armpit

2021-01-23

Systemic reaction (other): Lymph node swelling under armpit

Release 10 — 12 months, dose 2

2022-01-19

Symptoms: Diagnosed with idiopathic subglottic stenosis. Required surgery to open trachea.
Healthcare visit (other): Outpatient surgery

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSurgery · · ✓
SDLaryngeal stenosis · · ✓
SDTracheostomy · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release